213 related articles for article (PubMed ID: 17786351)
1. Reduced expression of TANGO in colon and hepatocellular carcinomas.
Arndt S; Bosserhoff AK
Oncol Rep; 2007 Oct; 18(4):885-91. PubMed ID: 17786351
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of CYLD in human colon and hepatocellular carcinomas.
Hellerbrand C; Bumes E; Bataille F; Dietmaier W; Massoumi R; Bosserhoff AK
Carcinogenesis; 2007 Jan; 28(1):21-7. PubMed ID: 16774947
[TBL] [Abstract][Full Text] [Related]
3. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
4. TANGO is a tumor suppressor of malignant melanoma.
Arndt S; Bosserhoff AK
Int J Cancer; 2006 Dec; 119(12):2812-20. PubMed ID: 17044017
[TBL] [Abstract][Full Text] [Related]
5. [Effects of ARNT2 gene on invasion and migration of human hepatocellular carcinoma HCCLM6 cell line].
Li WW; Wu WZ; Liang Y; Xiao CL; Tao ZH; Wang L; Sun HC; Fan J
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):27-31. PubMed ID: 20128965
[TBL] [Abstract][Full Text] [Related]
6. Interactions of TANGO and leukocyte integrin CD11c/CD18 regulate the migration of human monocytes.
Arndt S; Melle C; Mondal K; Klein G; von Eggeling F; Bosserhoff AK
J Leukoc Biol; 2007 Dec; 82(6):1466-72. PubMed ID: 17726152
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma.
Chen RN; Huang YH; Yeh CT; Liao CH; Lin KH
Cancer Res; 2008 Mar; 68(6):1697-706. PubMed ID: 18339849
[TBL] [Abstract][Full Text] [Related]
8. Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma.
Hellerbrand C; Mühlbauer M; Wallner S; Schuierer M; Behrmann I; Bataille F; Weiss T; Schölmerich J; Bosserhoff AK
Carcinogenesis; 2006 Jan; 27(1):64-72. PubMed ID: 16081515
[TBL] [Abstract][Full Text] [Related]
9. Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma.
Liu W; Liu Y; Zhu J; Wright E; Ding I; Rodgers GP
Clin Cancer Res; 2008 Feb; 14(4):1041-9. PubMed ID: 18281536
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of human ribosomal phosphoprotein P0 messenger RNA in hepatocellular carcinoma and colon carcinoma.
Barnard GF; Staniunas RJ; Bao S; Mafune K; Steele GD; Gollan JL; Chen LB
Cancer Res; 1992 Jun; 52(11):3067-72. PubMed ID: 1350508
[TBL] [Abstract][Full Text] [Related]
11. Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target.
Ito H; Funahashi S; Yamauchi N; Shibahara J; Midorikawa Y; Kawai S; Kinoshita Y; Watanabe A; Hippo Y; Ohtomo T; Iwanari H; Nakajima A; Makuuchi M; Fukayama M; Hirata Y; Hamakubo T; Kodama T; Tsuchiya M; Aburatani H
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3257-64. PubMed ID: 16740745
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
[TBL] [Abstract][Full Text] [Related]
13. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H
Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma].
Zhang G; Zhang SJ; Zhao YF; Wu Y; Li Z; Wang JX
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):499-502. PubMed ID: 17686315
[TBL] [Abstract][Full Text] [Related]
15. Down-regulated expression of the CCAAT/enhancer binding protein alpha and beta genes in human hepatocellular carcinoma: a possible prognostic marker.
Tomizawa M; Watanabe K; Saisho H; Nakagawara A; Tagawa M
Anticancer Res; 2003; 23(1A):351-4. PubMed ID: 12680236
[TBL] [Abstract][Full Text] [Related]
16. ING1a and ING1b different expressed in sporadic hepatocellular carcinoma.
Chen X; Du J; Zhu T
Pathol Biol (Paris); 2009 May; 57(3):e17-21. PubMed ID: 18450387
[TBL] [Abstract][Full Text] [Related]
17. Association of NET-1 gene expression with human hepatocellular carcinoma.
Chen L; Wang Z; Zhan X; Li DC; Zhu YY; Zhu J
Int J Surg Pathol; 2007 Oct; 15(4):346-53. PubMed ID: 17913940
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma.
Kim CJ; Song JH; Cho YG; Cao Z; Lee YS; Nam SW; Lee JY; Park WS
Histopathology; 2008 Apr; 52(5):552-9. PubMed ID: 18312352
[TBL] [Abstract][Full Text] [Related]
19. Expression of Hugl-1 is strongly reduced in malignant melanoma.
Kuphal S; Wallner S; Schimanski CC; Bataille F; Hofer P; Strand S; Strand D; Bosserhoff AK
Oncogene; 2006 Jan; 25(1):103-10. PubMed ID: 16170365
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
